Transcriptional profiling of MEF2-regulated genes in human neural progenitor cells derived from embryonic stem cells

Genomics Data

Volumn 3, Issue , 2015, Pages 24-27

  Chan, Shing Fai ^a   Huang, Xiayu ^a   McKercher, Scott R ^a   Zaidi, Rameez ^a   Okamoto, Shu Ichi ^a   Nakanishi, Nobuki ^a   Lipton, Stuart A ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Gene expression; Human neural stem cells; MEF2; Microarray; Neuronal differentiation; Transcription factor

Indexed keywords

MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DNA TRANSCRIPTION; DOWN REGULATION; EMBRYONIC STEM CELL; GENE; GENE ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MYOCYTE ENHANCER FACTOR 2 GENE; NEURAL STEM CELL; PRIORITY JOURNAL; RNA ISOLATION; UPREGULATION; VALIDATION PROCESS;

EID: 84922902454     PISSN: 22135960     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gdata.2014.10.022     Document Type: Article

References (10)

1. Cho E.G., Zaremba J.D., McKercher S.R., Talantova M., Tu S., Masliah E., Chan S.F., Nakanishi N., Terskikh A., Lipton S.A. MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model. PLoS One 2011, 6:e24027.
2. Gene expression microarray data quality control http://res.illumina.com/documents/products/technotes/technote_gene_expression_data_quality_control.pdf.
3. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
4. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 1995, 57:289-300.
5. Okamoto S., Nakamura T., Cieplak P., Chan S.F., Kalashnikova E., Liao L., Saleem S., Han X., Clemente A., Nutter A., Sances S., Brechtel C., Haus D., Haun F., Sanz-Blasco S., Huang X., Li H., Zaremba J.D., Cui J., Gu Z., Nikzad R., Harrop A., McKercher S.R., Godzik A., Yates J.R., Lipton S.A. S-Nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell death. Cell Rep. 2014, 8:217-228.
6. Le Meur N., Holder-Espinasse M., Jaillard S., Goldenberg A., Joriot S., Amati-Bonneau P., Guichet A., Barth M., Charollais A., Journel H., Auvin S., Boucher C., Kerckaert J.P., David V., Manouvrier-Hanu S., Saugier-Veber P., Frébourg T., Dubourg C., Andrieux J., Bonneau D. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or maturation is responsible for severe mental retardation with stereotypic movements, epilepsy, and/or cerebral malformations. J. Med. Genet. 2010, 47:22-29.
7. Nowakowska B.A., Obersztyn E., Szymańska K., Bekiesińska-Figatowska M., Xia Z., Ricks C.B., Bocian E., Stockton D.W., Szczałuba K., Nawara M., Patel A., Scott D.A., Cheung S.W., Bohan T.P., Stankiewicz P. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:1042-1051.
8. Zweier M., Gregor A., Zweier C., Engels H., Sticht H., Wohlleber E., Bijlsma E.K., Holder S.E., Zenker M., Rossier E., Grasshoff U., Johnson D.S., Robertson L., Firth H.V., Kraus Cornelia, Ekici A.B., Reis A., Rauch A. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum. Mutat. 2010, 31:722-733.
9. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
10. Parikshak N.N., Luo R., Zhang A., Won H., Lowe J.K., Chandran V., Horvath S., Geschwind D.H. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021.